Antimicrobial susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: Surveillance from 1993 to 2004 in Central Italy

Journal of Chemotherapy

Volumn 18, Issue 4, 2006, Pages 389-393

  Montagnani, F ^a   Stolzuoli, L ^a   Zanchi, A ^a   Cresti, S ^a   Cellesi, C ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Antibiotic resistance in Italy; Lincosamide resistance; Macrolide resistance; Pneumococcus susceptibility; Streptococcus susceptibility

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; GLYCOPEPTIDE; JOSAMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; OFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CHILD; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SENSITIVITY; HEALTH SURVEY; HUMAN; INFANT; ISOLATION PROCEDURE; ITALY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREVALENCE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 33749039446     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.4.389     Document Type: Article

References (41)

1. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; 290 (7509): 264-265.
2. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15 (July): 77-83.
3. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug resistant Streptococcus pneumoniae in the United States: an update from the Center for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174 (November): 986-993.
4. Jones RN. The impact of antimicrobial resistance: changing epidemiology of community-acquired respiratory-tract infections. Am J Health Syst Pharm 1999; 56 (S3): S4-S11.
5. Song JH, Lee NY, Ichiyama S, et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999; 28 (June): 1206-1211.
6. Alos JI, Aracil B, Oteo J, Gómez-Garcés JL, the Spanish Group for the Study of Infection in the Primary Health Care Setting (IAP-SEIMC). Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J Antimicrob Chemother 2003; 51 (2): 333-337.
7. EARSS (European Antimicrobial Resistance Surveillance System). Annual Report 2003; pp. 28-32, at http://www.earss.rivm.nl.
8. Fenoll A, Jado I, Vicioso D, Berron S, Yuste JE, Casal J. Streptococcus pneumoniae in children in Spain: 1990-1999. Acta Paediatr 2000; 89 (S435): 44-50.
9. Eriksson M, Henriques B, and Ekdahl K. Epidemiology of pneumococcal infections in Swedish children. Acta Paediatr 2000; 89 (S435): 35-39.
10. Spanjaard L, van der Ende A, Rumke H, Dankert, van Alphen L. Epidemiology of meningitis and bacteremia due to Streptococcus pneumoniae in The Netherlands. Acta Paediatr 2000; 89 (S435): 22-26.
11. Ziebold C, von Kries R, Siedler A, Schmitt HJ. Epidemiology of pneumococcal disease in children in Germany. Acta Paediatr 2000; 89 (S435): 17-21.
12. Petrosillo N, Pantosti A, Bordi E, et al. Prevalence, determinants and molecular epidemiology of Streptococcus pneumoniae isolates colonizing the nasopharynx of healthy children in Rome. Eur J Clin Microbiol Infect Dis 2002; 21 (3): 181-188.
13. Marchese A, Gualco L, Cochetti I, et al. Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents 2005; 26 (2): 138-145.
14. Albrich W, Monnet DM, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004; 10 (3): 514-517.
15. Bergman M, Huikko S, Pihlajamäki M, et al. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 2004; 38 (May): 1251-1256.
16. Boccia D, Alegiani SS, Pantosti A, Moro ML, Traversa G. The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy. Eur J Clin Pharmacol 2004; 60 (2): 115-119.
17. Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8 (3): 278-282.
18. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40 (8): 1817-1824.
19. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppälä H. Nomenclature for macrolides and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43 (12): 2823-2830.
20. Edelstein PH. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanism and resistance phenotypes. Clin Infect Dis 2004; 38 (S4): S322-S327.
21. Skinner R, Cundliffe E, Schmidt FJ. Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. J Biol Chem 1983; 258 (20): 12702-12706.
22. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995; 39 (3): 577-585.
23. Gattringer R, Sauermann R, Lagler H, et al. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary. Inter J Antimicrob Agents 2004; 24 (3): 92-95.
24. Green M, Martin JM, Barbadora KA, et al. Reemergence of macrolide resistance in pharyngeal isolates of group A Streptococci in Southwestern Pennsylvania. Antimicrob Agents Chemother 2004; 48 (2): 473-476.
25. Szczypa K, Sadowy E, Izdebski R, Hryniewicz W. A rapid increase in macrolides resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother 2004; 54 (4): 828-831.
26. Bingen E, Bidet P, Mihaila-Amrouche L, et al. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob Agents Chemother 2004; 48 (9): 3559-3562.
27. Farrell DJ, Jenkins SG. Distribution across the USA of macrolide resistance and macrolide resistance mechanism among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROJEKT US 2001-2002. J Antimicrob Chemother 2004; 54 (S1): i17-i22.
28. Song JH, Chang HH, Suh JY, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries : a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 2004; 53 (3):457-463.
29. Schito GC, Marchese A, Elkharrat D., Farrell D.J. and the PROTEKT Study Group. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study. J Chemother 2004; 16 (1): 13-22.
30. Savoia D, Avanzini C, Bosio K, et al. Macrolide resistance in group A streptococci. J Antimicrob Chemother 2000; 45 (1): 41-47.
31. Bassetti M, Manno G, Collidà A, et al. Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis 2000; 6 (2): 180-183.
32. Dicuonzo, G, Fiscarelli E, Ghepardi G, et al. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother 2002; 46 (12): 3987-3990.
33. Cornaglia G, Fontana R. Epidemiological survey of bacterial resistance in upper respiratory tract infections in Italy. Int J Antimicrob Agents 2000; 16 (3): 259-262.
34. Cocuzza CE, Mattina R, Mazzariol A, et al. High incidence of erythromycin-resistance Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study. Microb Drug Res 1997; 3 (4): 371-378.
35. Valisena S, Falci C, Mazzariol A, et al. Molecular typing of erythromycin-resistant Streptococcus pyogenes strains with the M phenotype isolated in Italy. Eur J Clin Microbiol Infect Dis 1999; 18 (4):260-264.
36. Giovanetti E, Montanari MP, Mingoia M, Varaldo PE. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother 1999; 43 (8): 1935-1940.
37. Latini L, Ronchetti MP, Merolla R, et al. Prevalence of mefE, erm and tet(M) genes in Streptococcus pneumoniae strains from central Italy. Int J Antimicrob Agents 1999; 13 (1): 29-33.
38. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press. 1999: 283-296.
39. Clinical and Laboratory Standards Institute/NCCLS. Performance standards for antimicrobial disk susceptibility tests; approved standard. Seventh edition: M2-A7. NCCLS 2001. Wayne, PA.
40. Clinical and Laboratory Standards Institute/NCCLS. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement: M100-S12. NCCLS 2002.Wayne, PA.
41. Decousser JW, Pina P, Viguier F, et al. Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob Agents Chemother 2004; 48 (9): 3636-3639.